EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A Novel Rat Model for Inflammatory Gut–Brain Interactions in Parkinson's Disease

Grace E Kendall, Conor F Underwood, Louise C Parr-Brownlie iD

European Journal of Neuroscience · 2025

DOI: 10.1111/ejn.16667 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neuroscience, 2025. Verfasst von Grace E Kendall und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, Brain Health Research Centre, University of Otago, Dunedin, New Zealand. Hauptthemen laut MEDLINE: Disease Models, Animal, Parkinson Disease, Colitis, Parkinsonian Disorders. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Brain Health Research Centre, New Zealand.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gut inflammation is a salient prodromal feature of Parkinson's disease (PD) implicated in pathologic processes leading to nigrostriatal dopaminergic degeneration. However, existing rodent models of PD are suboptimal for investigating the interaction between gut inflammation and neuropathology. This study aimed to develop a rat model of PD in which gut inflammation exacerbated PD symptoms induced by a parkinsonian lesion. This was achieved by combining the 6‐hydroxydopamine (6‐OHDA) rat model for PD and the dextran sodium sulfate (DSS) rat model for colitis. The model was characterised using behavioural tests, including reaching, step, gait, open‐field and cylinder tests, plus stereological quantification of substantia nigra (SN) DA neurodegeneration, and histological analysis of SN microglial activation and distal colon morphology. The combination of 6‐OHDA and DSS resulted in greater stool softening and bleeding, shorter colons and greater distal colon histological damage, when compared with the 6‐OHDA model. Additionally, 6‐OHDA and DSS rats displayed similar DA neurodegeneration, yet less SN microglial activation, when compared to 6‐OHDA rats that did not receive DSS. Finally, DSS + 6‐OHDA rats exhibited impaired forelimb motor function compared with 6‐OHDA rats, with decreased performance in reaching and step tests. In conclusion, DSS administration exacerbated forelimb motor dysfunction in 6‐OHDA rats. Behavioural changes in DSS + 6‐OHDA rats were associated with lower levels of microglial activation and similar levels of dopamine depletion compared with 6‐OHDA‐only rats. These results support that the DSS + 6‐OHDA rat model is a promising PD animal model to investigate deleterious gut–brain interactions in PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Disease Models, AnimalParkinson DiseaseColitisParkinsonian DisordersBrainInflammationAnimalsRatsOxidopamineMaleDextran SulfateRats, Sprague-DawleySubstantia NigraMicrogliaDopaminergic Neurons

Stichwörter der Autor:innen

6‐OHDAParkinson's diseasebehavioural ratdextran sodium sulfateinflammatory bowel disease

Substanzen

OxidopamineDextran Sulfate

Autor:innen und Institutionen

  • Department of Anatomy, Brain Health Research Centre, University of Otago, Dunedin, New Zealand.

ORCID-Profile: Louise C Parr-Brownlie

Förderung

  • Brain Health Research Centre, New Zealand

Zitieren

APA

Kendall, G. E., Underwood, C. F., & Parr-Brownlie, L. C. (2025). A Novel Rat Model for Inflammatory Gut–Brain Interactions in Parkinson's Disease. European Journal of Neuroscience. https://doi.org/10.1111/ejn.16667

Vancouver

Kendall GE, Underwood CF, Parr-Brownlie LC. A Novel Rat Model for Inflammatory Gut–Brain Interactions in Parkinson's Disease. European Journal of Neuroscience. 2025. doi:10.1111/ejn.16667

BibTeX
@article{Kendall2025,
  author = {Kendall, Grace E and Underwood, Conor F and Parr-Brownlie, Louise C},
  title = {A Novel Rat Model for Inflammatory Gut–Brain Interactions in Parkinson's Disease},
  journal = {European Journal of Neuroscience},
  year = {2025},
  doi = {10.1111/ejn.16667}
}
Kostenlos starten →